Compugen Ltd

Biotechnology company · Holon, Tel Aviv, Israel · Nasdaq: CGEN

Compugen Ltd is a biotechnology company headquartered in Holon, Tel Aviv, Israel. Its shares trade on Nasdaq under the ticker CGEN. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Compugen at a glance

Typebiotechnology company
HeadquartersHolon, Tel Aviv, Israel
Stock listingNasdaq: CGEN
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1119774

What does Compugen do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $20 million sold (2021).

Frequently asked questions about Compugen

Where is Compugen headquartered?

Compugen Ltd is headquartered in Holon, Tel Aviv, Israel.

What does Compugen do?

Compugen Ltd is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Compugen a public company?

Yes. Compugen Ltd trades on Nasdaq under the ticker CGEN.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.